Open access · US-GOV via ClinicalTrials.gov Clinical trial

Affiliated Hospital of Qingdao University

Authors not listed

The Affiliated Hospital of Qingdao University · 2021

Dysbiosis Human Randomized controlled trial

Abstract

Sarcopenia is a common complication in liver cirrhosis patients and has been confirmed that associated with poor prognosis. China has the world's largest burden of hepatitis B virus-related liver cirrhosis (HBV-related liver cirrhosis). However, the relationship between HBV-related liver cirrhosis patients with muscle mass loss and normal muscle mass is remain largely unknown. Our study aimed to reveal the metabolic profile and identify potential biomarkers of muscle mass loss in HBV-related liver cirrhosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2021). Affiliated Hospital of Qingdao University. <em>The Affiliated Hospital of Qingdao University</em>. https://clinicaltrials.gov/study/NCT05041348

Vancouver

Anonymous. Affiliated Hospital of Qingdao University. The Affiliated Hospital of Qingdao University. 2021.

BibTeX

@misc{anon2021Affili, title = {Affiliated Hospital of Qingdao University}, author = {Anonymous}, journal = {The Affiliated Hospital of Qingdao University}, year = {2021}, }